Archive Newsletter
-
09.17.25 -- Building Modularity Into Your Biopharmaceutical Production
9/17/2025
09/17/25 Cell & Gene Newsletter
-
09.17.25 -- Developing Interleukin-2 For Cell Therapies: Key Considerations
9/17/2025
09/17/25 Cell & Gene Newsletter
-
09.16.25 -- Reimagining the future of aseptic filling
9/16/2025
09/16/25 Cell & Gene Newsletter
-
09.16.25 -- STREAM Edition: Developing CRISPR-GPT, An AI-Driven Multi-Agent System
9/16/2025
09/16/25 Cell & Gene Newsletter
-
09.16.25 -- Lilly's Exploring A Universal AAV Purification Method
9/16/2025
09/16/25 Cell & Gene Newsletter
-
09.15.25 -- Reshape Your Cell Therapy Manufacturing For The Future
9/15/2025
09/15/25 Cell & Gene Newsletter
-
09.15.25 -- Contract Manufacturing Outsourcing Trends For Advanced Therapies In 2025 And Beyond
9/15/2025
09/15/25 Cell & Gene Newsletter
-
09.13.25 -- Cell & Gene Best Of August
9/13/2025
09/13/25 Cell & Gene Newsletter
-
09.12.25 -- EMA Guideline On Clinical-Stage ATMPs Comes Into Effect: On The Verge Of Convergence?
9/12/2025
09/12/25 Cell & Gene Newsletter
-
09.11.25 -- Using Slot Management To Bridge The Gap Between Capacity And CGTs
9/11/2025
09/11/25 Cell & Gene Newsletter